Skip to content Skip to footer
Paclitaxel Protein-Bound: Benefits, Reviews, Info, Side Effects!
Rx Details
Paclitaxel Protein-Bound
Abraxane, Taxol, Onxol
Albumin-bound paclitaxel
Prescription
Chemotherapy
Drugs
Prescription Only
cancer treatment, improved drug delivery, reduced side effects, increased efficacy, enhanced solubility, targeted therapy, improved patient outcomes
Allergic Reactions, Diarrhea, Fatigue, Hair Loss, Increased Risk Of Infection, Joint Or Muscle Pain, Liver Function Changes, Low Blood Cell Counts, Mouth Sores, Nausea, Numbness Or Tingling In Hands Or Feet, Shortness Of Breath, Swelling In Hands Or Feet, Vomiting, Weakness
Paclitaxel protein-bound, also known as nab-paclitaxel or Abraxane, is a chemotherapy medication used to treat various types of cancer, including breast cancer, non-small cell lung cancer, and pancreatic cancer. The dosage of paclitaxel protein-bound can vary based on the type of cancer being treated, the patient’s body surface area, and other individual factors such as overall health and response to treatment. For example, a common dosage for metastatic breast cancer is 260 mg/m² administered intravenously over 30 minutes every three weeks. However, dosages can differ for other conditions or in combination with other treatments. It’s important to note that the exact dosage and treatment schedule should be determined by a healthcare professional based on the specific circumstances of the patient. Always consult with a healthcare provider for personalized medical advice.
Breast cancer, non-small cell lung cancer, pancreatic cancer
Paclitaxel Protein-Bound has a generally safe safety profile.
Cyclosporine, St John’s wort, ketoconazole, rifampin
$1,000 – $2,000
$1,000 – $2,000

A Synopsis of

Paclitaxel Protein-Bound

Paclitaxel protein-bound, also known by its brand name Abraxane, is a chemotherapy drug used to treat various types of cancer, including breast, lung, and pancreatic cancer. This medication works by interfering with the growth and spread of cancer cells in the body.

One of the key benefits of paclitaxel protein-bound is its unique formulation, which includes albumin-bound nanoparticles that help deliver the medication directly to the tumor site. This targeted delivery system can enhance the effectiveness of the drug while reducing the risk of side effects commonly associated with traditional chemotherapy drugs.

It is important to follow your healthcare provider’s instructions carefully when taking paclitaxel protein-bound. This medication is typically administered intravenously by a healthcare professional in a clinical setting. The dosage and frequency of treatment will vary depending on the type and stage of cancer being treated.

Like all medications, paclitaxel protein-bound can cause side effects. Common side effects may include nausea, fatigue, hair loss, and low blood cell counts. It is important to report any side effects to your healthcare provider so they can be properly managed.

If you have any questions or concerns about paclitaxel protein-bound, do not hesitate to speak with your healthcare provider. They can provide you with more information about the medication, its potential benefits, and any potential risks associated with treatment. Remember, your healthcare team is here to support you throughout your cancer treatment journey.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN